A Study to Evaluate the Relative Bioavailability (BA) and Effect of Food on TAK-831 Tablet Formulations in Healthy Participants
Clinical trial NCT03706469 · COMPLETED
Trial details
- NCT number
- NCT03706469
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-18
- Primary completion
- 2018-12-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.